✦ LIBER ✦

Clinical prognostic factors associated with outcome in patients with renal cell cancer with prior tyrosine kinase inhibitors or immunotherapy treated with everolimus

✍ Scribed by Amato, Robert J.; Flaherty, Amber; Zhang, Yufeng; Ouyang, Fangqian; Mohlere, Virginia

Book ID: 121509826
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 989 KB
Volume: 32
Category: Article
ISSN: 1078-1439
DOI: 10.1016/j.urolonc.2013.09.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Are Tyrosine Kinase Inhibitors Still Act

Are Tyrosine Kinase Inhibitors Still Active in Patients With Metastatic Renal Cell Carcinoma Previously Treated With a Tyrosine Kinase Inhibitor and Everolimus? Experience of 36 Patients Treated in France in the RECORD-1 Trial

✍ Blesius, Aurore; Beuselinck, Benoit; Chevreau, Christine; Ravaud, Alain; Rolland 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 303 KB

Clinical factors associated with outcome

Clinical factors associated with outcome in patients with metastatic clear-cell renal cell carcinoma treated with vascular endothelial growth factor-targeted therapy

✍ Toni K. Choueiri; Jorge A. Garcia; Paul Elson; Mohamad Khasawneh; Saif Usman; Al 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

## Abstract ## BACKGROUND. Therapy targeted against the vascular endothelial growth factor (VEGF) pathway is a standard of care for patients with metastatic renal cell carcinoma (RCC). The identification of patients who are more likely to benefit from these agents is warranted. ## METHODS. In to

Levels of circulating CD45dimCD34+VEGFR2

Levels of circulating CD45dimCD34+VEGFR2+ progenitor cells correlate with outcome in metastatic renal cell carcinoma patients treated with tyrosine kinase inhibitors

✍ Farace, F; Gross-Goupil, M; Tournay, E; Taylor, M; Vimond, N; Jacques, N; Billio 📂 Article 📅 2011 🏛 Nature Publishing Group 🌐 English ⚖ 423 KB

Clinical efficacy and prognostic factors

Clinical efficacy and prognostic factors for overall survival in Japanese patients with metastatic renal cell cancer treated with sunitinib

✍ Takeshi Yuasa; Norihiko Tsuchiya; Shinji Urakami; Yohei Horikawa; Shintaro Narit 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 346 KB

Activity of Single-Agent Bevacizumab in

Activity of Single-Agent Bevacizumab in Patients With Metastatic Renal Cell Carcinoma Previously Treated With Vascular Endothelial Growth Factor Tyrosine Kinase Inhibitors

✍ Turnbull, James D.; Cobert, Julien; Jaffe, Tracy; Harrison, Michael R.; George, 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 345 KB

Clinical impact of amphiregulin expressi

Clinical impact of amphiregulin expression in patients with epidermal growth factor receptor (EGFR) wild-type nonsmall cell lung cancer treated with EGFR-tyrosine kinase inhibitors

✍ Myung Hee Chang; Hee Kyung Ahn; Jeeyun Lee; Chan-Kwon Jung; Yoon-La Choi; Yeon H 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB 👁 2 views